We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDMT icon
301
4D Molecular Therapeutics
FDMT
$526M
$265K 0.15%
24,519
+17,254
+237% +$286K
MITK icon
302
Mitek Systems
MITK
$762M
$265K 0.15%
+30,555
New +$309K
CSTL icon
303
Castle Biosciences
CSTL
$749M
$265K 0.15%
+9,282
New +$236K
VTRS icon
304
Viatris
VTRS
$20.1B
$264K 0.15%
+22,729
New +$262K
ONT
305
Onterris Inc
ONT
$710M
$263K 0.15%
+10,017
New +$324K
CSR
306
Centerspace
CSR
$936M
$263K 0.15%
+3,735
New +$269K
PJT icon
307
PJT Partners
PJT
$4.37B
$262K 0.15%
1,966
+1,065
+118% +$130K
FARO
308
DELISTED
Faro Technologies
FARO
$262K 0.15%
+13,680
New +$231K
LMAT icon
309
LeMaitre Vascular
LMAT
$2.18B
$261K 0.15%
+2,807
New +$243K
TM icon
310
Toyota
TM
$210B
$261K 0.15%
1,459
+754
+107% +$141K
MTW icon
311
Manitowoc
MTW
$516M
$260K 0.15%
+27,066
New +$282K
PFG icon
312
Principal Financial Group
PFG
$23.6B
$260K 0.15%
3,030
+831
+38% +$67.1K
NXDR
313
Nextdoor Holdings
NXDR
$835M
$260K 0.15%
+104,685
New +$269K
PTC icon
314
PTC
PTC
$13.7B
$259K 0.15%
1,436
+701
+95% +$123K
IVT icon
315
InvenTrust Properties
IVT
$2.84B
$259K 0.15%
+9,141
New +$254K
HCI icon
316
HCI Group
HCI
$2.28B
$259K 0.15%
+2,419
New +$229K
ZBRA icon
317
Zebra Technologies
ZBRA
$12.4B
$259K 0.15%
699
+408
+140% +$137K
EHAB
318
DELISTED
Enhabit
EHAB
$259K 0.15%
+32,751
New +$285K
UWMC icon
319
UWM Holdings
UWMC
$621M
$258K 0.15%
+30,298
New +$255K
CPT icon
320
Camden Property Trust
CPT
$11.3B
$258K 0.15%
+2,086
New +$247K
EGP icon
321
EastGroup Properties
EGP
$11.5B
$257K 0.15%
1,378
+258
+23% +$47.6K
ENR icon
322
Energizer
ENR
$1.44B
$255K 0.15%
+8,038
New +$242K
FRT icon
323
Federal Realty Investment Trust
FRT
$10.9B
$255K 0.15%
2,218
+1,377
+164% +$154K
AVY icon
324
Avery Dennison
AVY
$12.3B
$255K 0.15%
1,155
+662
+134% +$143K
FHI icon
325
Federated Hermes
FHI
$4.4B
$255K 0.14%
+6,927
New +$237K

Similar funds

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.